Showing results (101-110 of 657) with videos related to
Sort By:
Pageof 66
Health Affairs (Project Hope)|June 5, 2018
Network Optimization And The Continuity Of Physicians In Medicaid Managed CareChima D Ndumele, Becky Staiger, Joseph S Ross, et al.Circulation. Cardiovascular Quality and Outcomes|February 4, 2010
Determinants of cardiac catheterization use in older Medicare patients with acute myocardial infarctionDennis T Ko, Joseph S Ross, Yongfei Wang, et al.Journal of Pharmaceutical Policy and Practice|October 6, 2025
Therapeutic benefit of the most expensive drugs covered by Medicare and MedicaidTiffany Enxia Jiang, Reshma Ramachandran, Kerstin N Vokinger, et al.Clinical Trials (London, England)|April 7, 2026
Evidence supporting European Medicines Agency drug approvals (2020-2023): A cross-sectional study of trial design and outcomesMaximilian Siebert, Laura Caquelin, Florian Naudet, et al.Journal of the American Geriatrics Society|March 28, 2018
National Prescribing Trends for High-Risk Anticholinergic Medications in Older AdultsTaeho Greg Rhee, Yookyung Christy Choi, Gregory M Ouellet, et al.Medical Care|January 14, 2016
Preventive Care Quality of Medicare Accountable Care Organizations: Associations of Organizational Characteristics With PerformanceBenjamin B Albright, Valerie A Lewis, Joseph S Ross, et al.Annals of Internal Medicine|August 20, 2008
The ADVANTAGE seeding trial: a review of internal documentsKevin P Hill, Joseph S Ross, David S Egilman, et al.Medical Care|May 16, 2012
Association of chronic diseases and impairments with disability in older adults: a decade of change?William W Hung, Joseph S Ross, Kenneth S Boockvar, et al.Health Affairs (Project Hope)|July 8, 2016
Population Of US Practicing Psychiatrists Declined, 2003-13, Which May Help Explain Poor Access To Mental Health CareTara F Bishop, Joanna K Seirup, Harold Alan Pincus, et al.BMJ Medicine|March 20, 2023
Vibration of effect in more than 16 000 pooled analyses of individual participant data from 12 randomised controlled trials comparing canagliflozin and placebo for type 2 diabetes mellitus: multiverse analysisHenri Gouraud, Joshua D Wallach, Rémy Boussageon, et al.Pageof 66